AQP4 and Alzheimer disease: Patients with AD have increased AQP4 immunoreactivity but markedly reduced expression of polarized AQP4 when compared with age-matched healthy controls (as observed by postmortem analysis of tissue samples) [85], confirming similar observations in animal models of AD [84].